Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 31 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04045470
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06860880
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- North Carolina Basnight Cancer Hospital Chapel Hill, North Carolina, United States
Recruiting
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
NCT05956041
- Conditions
- Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT03932279
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT05680558
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
NCT07356245
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, Graft Versus Host Disease, +25 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT07047885
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06588868
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
- Locations
-
- AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy
- Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +22 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT04014374
- Conditions
- ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
- Locations
-
- CIBMTR Milwaukee, Wisconsin, United States
Recruiting
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
NCT06436677
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
Enrolling by Invitation
Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash
NCT06665490
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Northwestern University Department of Dermatology Chicago, Illinois, United States
Not Yet Recruiting
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
NCT05728879
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Dermatology CTU Chicago, Illinois, United States
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
NCT06651203
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides
NCT05205902
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
Not specified
NCT06113081
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +17 more
- Locations
-
- Clinica di Ematologia - AOU Ospedali Riuniti delle Marche Ancona, Italy
- S.C. Ematologia e Trapianto emopoietico - A.O. S.Giuseppe Moscati Avellino, Italy
- Clinica Dermatologia - A.O.U. Policlinico Consorziale Bari, Italy
- U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
NCT05872854
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
NCT01460914
- Conditions
- Cutaneous T Cell Lymphoma, Graft Versus Host Disease, Graft vs Host Disease, +11 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT02192021
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- UPMC Department of Dermatology Pittsburgh, Pennsylvania, United States